Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma

Yoshitaka Takuma, Kazuhiro Nouso, Yoshiyuki Kobayashi, Shinichiro Nakamura, Hironori Tanaka, Eiji Matsumoto, Tatsuya Fujikawa, Mayumi Suzuki, Tadashi Hanafusa, Yasushi Shiratori

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background and Aim: Telomerase activation is essential for the immortality of cancer cells. The expression of telomerase reverse transcriptase (hTERT), the catalytic component of the telomerase complex, regulates telomerase activity in human cancers. Amplification of the hTERT gene, located at chromosome 5p, is thought to be a potential genetic event contributing to telomerase activation in sporadic tumors. Methods: The amplification of the hTERT gene was examined in 46 surgically resected hepatocellular carcinomas (HCC) by real-time polymerase chain reaction and the status was compared with the expression of hTERT mRNA and clinicopathological parameters. Results: Amplified hTERT genes were found in 21.7% (10/46) of HCC. The incidence of amplified hTERT genes in poorly differentiated HCC (6/12, 50%) was significantly higher than that in highly to moderately differentiated HCC (4/34, 11.8%; P = 0.012). Tumor size in those cases with hTERT gene amplification was larger compared to those cases with no amplification (P = 0.047). Amplification of the hTERT gene was not observed in non-cancerous tissues. The hTERT mRNA level did not correlate with the number of hTERT genes. Conclusions: Based on these results, it is thought that hTERT gene amplification is a cancer-specific event, and may furthermore contribute to the dedifferentiation and development of HCC. However, hTERT gene overexpression was rarely due to an increased hTERT gene copy number in HCC.

Original languageEnglish
Pages (from-to)1300-1304
Number of pages5
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume19
Issue number11
DOIs
Publication statusPublished - 2004

Fingerprint

Gene Amplification
Telomerase
Hepatocellular Carcinoma
Neoplasms
Genes
Messenger RNA
Gene Dosage
Human Activities
Real-Time Polymerase Chain Reaction
Chromosomes
Incidence

Keywords

  • Gene amplification
  • Hepatocellular carcinoma
  • Real-time polymerase chain reaction
  • Telomerase reverse transcriptase

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Takuma, Y., Nouso, K., Kobayashi, Y., Nakamura, S., Tanaka, H., Matsumoto, E., ... Shiratori, Y. (2004). Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology (Australia), 19(11), 1300-1304. https://doi.org/10.1111/j.1440-1746.2004.03447.x

Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. / Takuma, Yoshitaka; Nouso, Kazuhiro; Kobayashi, Yoshiyuki; Nakamura, Shinichiro; Tanaka, Hironori; Matsumoto, Eiji; Fujikawa, Tatsuya; Suzuki, Mayumi; Hanafusa, Tadashi; Shiratori, Yasushi.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 19, No. 11, 2004, p. 1300-1304.

Research output: Contribution to journalArticle

Takuma, Y, Nouso, K, Kobayashi, Y, Nakamura, S, Tanaka, H, Matsumoto, E, Fujikawa, T, Suzuki, M, Hanafusa, T & Shiratori, Y 2004, 'Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma', Journal of Gastroenterology and Hepatology (Australia), vol. 19, no. 11, pp. 1300-1304. https://doi.org/10.1111/j.1440-1746.2004.03447.x
Takuma, Yoshitaka ; Nouso, Kazuhiro ; Kobayashi, Yoshiyuki ; Nakamura, Shinichiro ; Tanaka, Hironori ; Matsumoto, Eiji ; Fujikawa, Tatsuya ; Suzuki, Mayumi ; Hanafusa, Tadashi ; Shiratori, Yasushi. / Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. In: Journal of Gastroenterology and Hepatology (Australia). 2004 ; Vol. 19, No. 11. pp. 1300-1304.
@article{bd1202d0201844c1a6365c70a7662292,
title = "Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma",
abstract = "Background and Aim: Telomerase activation is essential for the immortality of cancer cells. The expression of telomerase reverse transcriptase (hTERT), the catalytic component of the telomerase complex, regulates telomerase activity in human cancers. Amplification of the hTERT gene, located at chromosome 5p, is thought to be a potential genetic event contributing to telomerase activation in sporadic tumors. Methods: The amplification of the hTERT gene was examined in 46 surgically resected hepatocellular carcinomas (HCC) by real-time polymerase chain reaction and the status was compared with the expression of hTERT mRNA and clinicopathological parameters. Results: Amplified hTERT genes were found in 21.7{\%} (10/46) of HCC. The incidence of amplified hTERT genes in poorly differentiated HCC (6/12, 50{\%}) was significantly higher than that in highly to moderately differentiated HCC (4/34, 11.8{\%}; P = 0.012). Tumor size in those cases with hTERT gene amplification was larger compared to those cases with no amplification (P = 0.047). Amplification of the hTERT gene was not observed in non-cancerous tissues. The hTERT mRNA level did not correlate with the number of hTERT genes. Conclusions: Based on these results, it is thought that hTERT gene amplification is a cancer-specific event, and may furthermore contribute to the dedifferentiation and development of HCC. However, hTERT gene overexpression was rarely due to an increased hTERT gene copy number in HCC.",
keywords = "Gene amplification, Hepatocellular carcinoma, Real-time polymerase chain reaction, Telomerase reverse transcriptase",
author = "Yoshitaka Takuma and Kazuhiro Nouso and Yoshiyuki Kobayashi and Shinichiro Nakamura and Hironori Tanaka and Eiji Matsumoto and Tatsuya Fujikawa and Mayumi Suzuki and Tadashi Hanafusa and Yasushi Shiratori",
year = "2004",
doi = "10.1111/j.1440-1746.2004.03447.x",
language = "English",
volume = "19",
pages = "1300--1304",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma

AU - Takuma, Yoshitaka

AU - Nouso, Kazuhiro

AU - Kobayashi, Yoshiyuki

AU - Nakamura, Shinichiro

AU - Tanaka, Hironori

AU - Matsumoto, Eiji

AU - Fujikawa, Tatsuya

AU - Suzuki, Mayumi

AU - Hanafusa, Tadashi

AU - Shiratori, Yasushi

PY - 2004

Y1 - 2004

N2 - Background and Aim: Telomerase activation is essential for the immortality of cancer cells. The expression of telomerase reverse transcriptase (hTERT), the catalytic component of the telomerase complex, regulates telomerase activity in human cancers. Amplification of the hTERT gene, located at chromosome 5p, is thought to be a potential genetic event contributing to telomerase activation in sporadic tumors. Methods: The amplification of the hTERT gene was examined in 46 surgically resected hepatocellular carcinomas (HCC) by real-time polymerase chain reaction and the status was compared with the expression of hTERT mRNA and clinicopathological parameters. Results: Amplified hTERT genes were found in 21.7% (10/46) of HCC. The incidence of amplified hTERT genes in poorly differentiated HCC (6/12, 50%) was significantly higher than that in highly to moderately differentiated HCC (4/34, 11.8%; P = 0.012). Tumor size in those cases with hTERT gene amplification was larger compared to those cases with no amplification (P = 0.047). Amplification of the hTERT gene was not observed in non-cancerous tissues. The hTERT mRNA level did not correlate with the number of hTERT genes. Conclusions: Based on these results, it is thought that hTERT gene amplification is a cancer-specific event, and may furthermore contribute to the dedifferentiation and development of HCC. However, hTERT gene overexpression was rarely due to an increased hTERT gene copy number in HCC.

AB - Background and Aim: Telomerase activation is essential for the immortality of cancer cells. The expression of telomerase reverse transcriptase (hTERT), the catalytic component of the telomerase complex, regulates telomerase activity in human cancers. Amplification of the hTERT gene, located at chromosome 5p, is thought to be a potential genetic event contributing to telomerase activation in sporadic tumors. Methods: The amplification of the hTERT gene was examined in 46 surgically resected hepatocellular carcinomas (HCC) by real-time polymerase chain reaction and the status was compared with the expression of hTERT mRNA and clinicopathological parameters. Results: Amplified hTERT genes were found in 21.7% (10/46) of HCC. The incidence of amplified hTERT genes in poorly differentiated HCC (6/12, 50%) was significantly higher than that in highly to moderately differentiated HCC (4/34, 11.8%; P = 0.012). Tumor size in those cases with hTERT gene amplification was larger compared to those cases with no amplification (P = 0.047). Amplification of the hTERT gene was not observed in non-cancerous tissues. The hTERT mRNA level did not correlate with the number of hTERT genes. Conclusions: Based on these results, it is thought that hTERT gene amplification is a cancer-specific event, and may furthermore contribute to the dedifferentiation and development of HCC. However, hTERT gene overexpression was rarely due to an increased hTERT gene copy number in HCC.

KW - Gene amplification

KW - Hepatocellular carcinoma

KW - Real-time polymerase chain reaction

KW - Telomerase reverse transcriptase

UR - http://www.scopus.com/inward/record.url?scp=8344251744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8344251744&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2004.03447.x

DO - 10.1111/j.1440-1746.2004.03447.x

M3 - Article

VL - 19

SP - 1300

EP - 1304

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 11

ER -